To determine the identity of SLUG+ and TAL1+ cells in GBM, we proceeded with an extensive and thorough characterization using specific combinations of immunofluorescence markers in two GBM biopsies (GBM#24 and #26). The gene discussed is SNAI2; the disease is glioblastoma.